On the morning of December 27, 2022, the Suzhou Institute of Biomedical Engineering Technology of the Chinese Academy of Sciences and ZD medical signed a strategic cooperation agreement in Hangzhou. The two parties will focus on the ophthalmic medical device industry and devote themselves to the innovation and breakthrough of new technologies in the field of ophthalmic clinical application to benefit the general public eye disease patients.
For a long time, due to the highly subdivided and highly specialized ophthalmic diseases, people's awareness and attention to ophthalmic diseases is limited, resulting in a low level of ophthalmological diagnosis and treatment in my country, and the development of domestic ophthalmic drugs and devices is also slow At a very early stage, still import-dominated.

The purpose of the two parties this time is to promote the innovation and breakthrough of new technologies of China's domestic high-end ophthalmic medical devices, and realize the provision of domestic excellent and high-quality ophthalmic medical devices and system solutions for eye disease diagnosis and treatment for the majority of eye patients.

In the future, ZD medical will continue to increase investment in research and development, and through this cooperation, together with the strong scientific and technological research and development strength of Suzhou Institute of Medical Engineering, Chinese Academy of Sciences, will continue to develop and innovate, comprehensively promote, and improve new technologies in the fields of fundus, dry eye and optometry. Innovation and breakthroughs provide a more complete solution for the diagnosis and treatment of eye diseases for the majority of eye patients.